Ian D. Wall
GlaxoSmithKline (Netherlands)(NL)
Publications by Year
Research Areas
Protein Structure and Dynamics, Protein Degradation and Inhibitors, Computational Drug Discovery Methods, Multiple Myeloma Research and Treatments, Enzyme Structure and Function
Most-Cited Works
- → A Critical Assessment of Docking Programs and Scoring Functions(2005)1,688 cited
- → Exploring Ligand Stability in Protein Crystal Structures Using Binding Pose Metadynamics(2020)135 cited
- → Rapid and Reliable Binding Affinity Prediction of Bromodomain Inhibitors: A Computational Study(2016)81 cited
- → Binding Constants of Neuraminidase Inhibitors: An Investigation of the Linear Interaction Energy Method(1999)73 cited
- → Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening(2020)70 cited
- → The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor(2020)63 cited
- → Bioinformatics and molecular modelling approaches to GPCR oligomerization(2009)63 cited
- → Design and Synthesis of a Highly Selective and In Vivo-Capable Inhibitor of the Second Bromodomain of the Bromodomain and Extra Terminal Domain Family of Proteins(2020)52 cited
- → Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit(2021)45 cited
- → Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity(2020)32 cited